BCL2L11 and cancer: We selected two predicted targets of the miR-106b~25 cluster, cyclin-dependent kinase inhibitor 1A (p21WAF1/CIP1) and BCL2-like 11 (BIM) [18], based on protein function and relevance of these proteins in cancer.